Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients: A 14-week Randomized, Double-blind and Placebo-controlled Trial

NCT01105481 is registered in ClinicalTrials.gov with National Health Research Institutes, Taiwan as lead sponsor.

NCT NCT01105481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01105481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients: A 14-week Randomized, Double-blind and Placebo-controlled Trial
Lead sponsor
National Health Research Institutes, Taiwan
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
June 30, 2008
Enrollment
273 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

treatment-resistant schizophrenia